Xiao Feng, Hu Ya-guo, Wu Shi-nan, Shou Qi-yang, Cai Yue-qin, Wang Hui-ming, Wang Hui
Zhongguo Zhong Yao Za Zhi. 2015 May;40(10):2014-8.
To study the protective effect of astragalus saponin extracts (AS) on kidneys of diabetic rats. Totally 32 diabetic rats induced by streptozotocin (STZ) were divided into AS high and low dose groups, the positive control group and the model group (DM group) and orally administered with 50 mg x- kg(-1) x d(-1) AS 200, 25 mg x kg(-1) x d(-1) valsartan, 10 mL x kg(-1) x d(1) physiological saline, respectively. Another 8 healthy rats were collected in the normal control group (NC group, physiological saline 10 mL x kg(-1). d(-1)). All rats were treated for consecutively 6 weeks. After the administration, the body weight was measured every week, the concentration of blood glucose was monitored on week 2, 4 and 6. The total urine and total urinary protein (U-TP) in 24 h were measured by the metabolic cage method on week 6; At the end of week 6, blood samples were collected from hearts to detect blood urea nitrogen (BUN), serum creatinine (Scr), uric acid (UA) , total cholesterol (CH) triglyceride (TG) by biochemical methods. Kidneys were collect to calculate the kidney hypertrophy index and observe the pathological sections. The laboratory results show that in the DM group, the blood glucose, metabolic cost in 24 h, kidney hypertrophy index, U-TP, BUN, Scr, UA, TG were significantly higher than that in the NC group (P < 0.01, P < 0.05) , with significant pathological changes; After the intervention with AS, the metabolic value in 24 h, kidney hypertrophy index, U-TP, BUN, Scr, UA, TG were significantly lower in the high dose group (P < 0.01, P < 0.05), and the kidney hypertrophy index, BUN, Scr, UA, TG in the low dose group were also significantly lower (P < 0.05), with slight reduction in renal pathological changes in both groups. In conclusion, Astragalus saponin extracts have a certain protective effect on kidneys of diabetic rats.
研究黄芪皂苷提取物(AS)对糖尿病大鼠肾脏的保护作用。将32只链脲佐菌素(STZ)诱导的糖尿病大鼠分为AS高、低剂量组、阳性对照组和模型组(DM组),分别灌胃给予50mg·kg⁻¹·d⁻¹ AS、200mg·kg⁻¹·d⁻¹缬沙坦、10mL·kg⁻¹·d⁻¹生理盐水。另取8只健康大鼠作为正常对照组(NC组,给予10mL·kg⁻¹·d⁻¹生理盐水)。所有大鼠连续治疗6周。给药后,每周测量体重,在第2、4、6周监测血糖浓度。第6周采用代谢笼法测定24h总尿量和总尿蛋白(U-TP);在第6周结束时,从心脏采集血样,采用生化方法检测血尿素氮(BUN)、血清肌酐(Scr)、尿酸(UA)、总胆固醇(CH)、甘油三酯(TG)。摘取肾脏计算肾脏肥大指数并观察病理切片。实验结果显示,在DM组中,血糖、24h代谢指标、肾脏肥大指数、U-TP、BUN、Scr、UA、TG均显著高于NC组(P<0.01,P<0.05),且有明显病理改变;AS干预后,高剂量组24h代谢指标、肾脏肥大指数、U-TP、BUN、Scr、UA、TG均显著降低(P<0.01,P<0.05),低剂量组肾脏肥大指数、BUN、Scr、UA、TG也显著降低(P<0.05),两组肾脏病理改变均有轻度减轻。综上所述,黄芪皂苷提取物对糖尿病大鼠肾脏具有一定的保护作用。